Kairos Pharma, Ltd. (KAPA)

Kairos Pharma will go public soon, but the exact IPO date is still unknown.

IPO Price

$4.00

Shares Offered

1,550,000

Deal Size

$6.20M

Kairos Pharma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021
Net Income	-1.05	-2.15
Depreciation & Amortization	0.57	0.24
Other Operating Activities	0.13	1.49
Operating Cash Flow	-0.35	-0.41
Change in Investments	-	-0.11
Investing Cash Flow	-	-0.11
Share Issuance / Repurchase	-	0.25
Debt Issued / Paid	0.89	0.33
Other Financing Activities	-0.17	-
Financing Cash Flow	0.72	0.58
Net Cash Flow	0.36	0.06
Free Cash Flow	-0.35	-0.41

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).